查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555490

长效给药技术和服务市场，按材料、剂型、最终用户、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Long-Acting Drug Delivery Technologies and Services Market, By Material, By Dosage Form, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 386 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年长效给药技术及服务市场规模为122.3423亿美元，2024年至2032年复合年增长率为11.2%。

长效药物传输技术与服务市场-市场动态

患者依从性的提高以及高血压和精神疾病的盛行率预计将推动市场需求

糖尿病、高血压、癌症和精神疾病越来越常见，通常需要长期治疗。长效製剂可减少给药频率并提高患者依从性，预计将促进市场成长。人们越来越重视预防性医疗保健，包括使用长效药物在病情恶化之前进行控制，从而提高生活品质并降低长期医疗费用。

生物製剂和生物相似药长效製剂的开发正在扩大市场。这些药物通常需要复杂的递送系统才能随着时间的推移保持稳定性和有效性。製药技术的创新，例如奈米药物传输系统、先进聚合物和改进的配方技术，使长效药物传输系统更加有效和通用。更少的剂量和更少的给药频率带来的更多便利鼓励患者坚持他们的治疗计划，这可以带来更好的健康结果并降低医疗成本。所有这些好处预计将有助于市场成长。

长效药物传输技术与服务市场-关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 11.2% 左右的复合年增长率成长

根据材料细分，由于其长效药物输送效率高，预计聚合物细分市场将在 2023 年显示最大的市场份额。

从剂型细分来看，长效注射剂由于其给药效果较好且反应速度快，将成为 2023 年领先的剂型。

根据最终用户细分，由于製药和生物技术行业对药品的高需求，製药和生物技术公司细分市场将在 2023 年成为领先的最终用户细分市场。

从地区来看，由于政府和 FDA 的支持，北美是 2023 年的主要收入来源。

长效药物输送技术与服务市场細項分析：

全球长效药物传输技术和服务市场根据材料、剂型、最终用户和地区进行细分。

市场依材料分为两类：聚合物基和非聚合物基。基于聚合物的细分市场主导市场。聚合物药物具有长效耐久性，因此在市场上越来越受欢迎。

根据剂型，市场分为四类：长效注射剂、作用植入剂、长效口服剂和其他。长效注射剂市场占据主导地位。注射剂对常见的呼吸系统疾病具有很高的效率，这推动了细分市场的成长。

根据最终用户，市场分为三类：製药和生技公司、研发等。製药和生物技术公司领域在市场中占据主导地位，预计在预测期内将保持其高度主导地位。不断增长的药物开发和製药技术正在推动市场需求。

长效给药技术与服务市场-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。由于先进的医疗基础设施、新技术的采用率以及大量的研发投资，美国在全球市场中占有重要份额。欧洲是一个越来越重视个人化医疗和先进药物输送系统的主要市场。主要市场包括德国、法国和英国。拉丁美洲是一个新兴市场，医疗保健服务范围不断扩大，医疗保健基础设施投资不断增加。

长效药物输送技术与服务市场-竞争格局：

长效给药技术和服务市场的特征是激烈的竞争和持续的创新。该领域的公司采取了各种策略，包括技术进步、伙伴关係、协作和市场扩张。公司正在投资奈米技术、可生物降解聚合物和先进的微球技术，以增强长效药物传输系统。製药公司、技术公司和学术机构之间的策略合作伙伴关係对于推动长效药物传输技术和扩大市场范围至关重要。

最新进展：

2023 年 2 月，EyePoint Pharmaceuticals 和 Rallybio 达成了一项研究协议，利用 Durasert(R) 技术评估 Rallybio 的补体成分 5 (C5) 抑制剂。

2023年4月，美国FDA核准了大冢开发的长效注射混悬液ABILIFY ASIMTUFII，每两个月肌肉註一次，用于治疗精神分裂症。

目录

第一章：长效药物传输技术与服务市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 长效药物传输技术和服务市场片段（按材料）
    • 长效药物传递技术与服务市场片段（按剂型）
    • 最终用户的长效药物传输技术和服务市场片段
    • 按国家/地区分類的长效药物传输技术和服务市场片段
    • 按地区分類的长效药物传输技术与服务市场片段
  • 竞争洞察

第 3 章：长效给药技术与服务主要市场趋势

  • 长效给药技术与服务市场驱动因素
    • 市场驱动因素的影响分析
  • 长效给药技术与服务市场限制
    • 市场限制影响分析
  • 长效给药技术与服务市场机会
  • 长效给药技术与服务市场未来趋势

第 4 章：长效药物传递技术与服务业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：长效药物传递技术与服务市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：长效药物传输技术与服务市场格局

  • 2023 年长效给药技术与服务市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：长效药物传递技术与服务市场 - 按材料

  • 概述
    • 按材料分類的细分市场份额分析
    • 聚合物基
    • 非聚合物基

第 8 章：长效药物传递技术与服务市场 - 按剂型

  • 概述
    • 按剂型分類的细分市场占有率分析
    • 长效注射剂
    • 长效植入式
    • 长效口服
    • 其他的

第 9 章：长效药物传输技术与服务市场 - 按最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 製药和生物技术公司
    • 研究与开发
    • 其他的

第 10 章：长效药物传输技术与服务市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 长效给药技术与服务北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按材料）
    • 北美市场规模与预测（按剂型）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 长效给药技术与服务欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按材料）
    • 欧洲市场规模与预测（按剂型）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 长效给药技术及服务亚太地区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按材料）
    • 亚太地区市场规模与预测（按剂型）
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 长效给药技术与服务拉丁美洲主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按材料）
    • 拉丁美洲市场规模与预测（按剂型）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 长效给药技术和服务中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按材料）
    • 中东和非洲市场规模及预测（按剂型）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 长效给药技术与服务业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Roche Holding AG
    • Novartis International AG
    • Johnson & Johnson
    • Boehringer Ingelheim
    • Bristol-Myers Squibb
    • Viatris Inc.
    • ALZA Corporation
    • Eli Lilly and Company
    • Merck & Co., Inc.
    • Sanofi SA
    • AbbVie Inc.
    • Gilead Sciences, Inc.
    • GlaxoSmithKline plc
    • AstraZeneca plc
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3639

REPORT HIGHLIGHT

Long-Acting Drug Delivery Technologies and Services Market size was valued at USD 12,234.23 Million in 2023, expanding at a CAGR of 11.2% from 2024 to 2032.

Long-Acting Drug Delivery Technologies and Services imply advanced methods and systems designed to administer medications over extended periods with fewer doses compared to traditional methods. These technologies aim to improve patient adherence, enhance therapeutic efficacy, and reduce the frequency of administration.

Long-Acting Drug Delivery Technologies and Services Market- Market Dynamics

Increasing patient adherence and the prevalence of hypertension, and psychiatric diseases are expected to propel market demand

Diabetes, hypertension, cancer, and psychiatric disorders are increasingly common and often require long-term management. Long-acting formulations reduce the frequency of dosing and improve patient adherence which is expected to bolster market growth. There is a growing emphasis on preventive healthcare, which includes using long-acting medications to manage conditions before they become severe, thereby improving quality of life and reducing long-term healthcare costs.

The development of long-acting formulations for biologics and biosimilars is expanding the market. These drugs often require complex delivery systems to maintain stability and effectiveness over time. Innovations in pharmaceutical technology, such as nano-based drug delivery systems, advanced polymers, and improved formulation techniques, are making long-acting drug delivery systems more effective and versatile. Enhanced convenience from fewer doses and less frequent administration encourages patients to stick to their treatment plans, which can lead to better health outcomes and reduced healthcare costs. All these benefits are projected to contribute to market growth.

Long-Acting Drug Delivery Technologies and Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.2% over the forecast period (2024-2032)

Based on Material segmentation, the polymer-based segment was predicted to show maximum market share in the year 2023, owing to its high efficiency in long-acting drug delivery.

Based on Dosage Form segmentation, long acting injectables segment was the leading Dosage Form in 2023, owing to its greater effects in drug delivery & quick response.

Based on End User segmentation, the pharmaceutical & biotech companies' segment was the leading End User segment in 2023, owing to the high demand for drugs in the pharma & biotech industries.

Based on region, North America was the leading revenue generator in 2023, due to the government & FDA support.

Long-Acting Drug Delivery Technologies and Services Market- Segmentation Analysis:

The Global Long-Acting Drug Delivery Technologies and Services Market is segmented based on Material, Dosage Form, End User, and Region.

The market is divided into two categories based on Material: polymer-based and non-polymer based. The polymer-based segment dominates the market. Polymer-based drugs provide long-acting durability and thus are gaining more traction in the market.

The market is divided into four categories based on Dosage Form: long acting injectables, acting implantables, long-acting oral, and others. The long acting injectables segment dominates the market. Injectables have high efficiency in common respiratory disorders which is fueling segment growth.

The market is divided into three categories based on End Users: pharmaceutical & biotech companies, research & development, and others. The pharmaceutical & biotech companies segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing number of drug development and pharma technologies are boosting market demand.

Long-Acting Drug Delivery Technologies and Services Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. The United States holds a significant share of the global market due to advanced healthcare infrastructure, high adoption rates of new technologies, and substantial R&D investments. Europe is a major market with a growing emphasis on personalized medicine and advanced drug delivery systems. Key markets include Germany, France, and the UK. Latin America is an emerging market with expanding healthcare access and increasing investments in healthcare infrastructure.

Long-Acting Drug Delivery Technologies and Services Market- Competitive Landscape:

The long-acting drug delivery technologies and services market is characterized by significant competition and ongoing innovations. Companies in this space are engaged in various strategies, including technological advancements, partnerships, collaboration, and market expansions. Companies are investing in nanotechnology, biodegradable polymers, and advanced microsphere technologies to enhance long-acting drug delivery systems. Strategic partnerships between pharmaceutical companies, technology firms, and academic institutions are crucial for advancing long-acting drug delivery technologies and expanding market reach.

Recent Developments:

In February 2023, EyePoint Pharmaceuticals and Rallybio formed a research agreement to assess Rallybio's inhibitors of complement component 5 (C5) using Durasert(R) technology.

In April 2023, the U.S. FDA approved ABILIFY ASIMTUFII, a long-acting injectable suspension, developed by Otsuka, administered intramuscularly once every two months for the treatment of schizophrenia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET KEY PLAYERS

  • Pfizer Inc.
  • Roche Holding AG
  • Novartis International AG
  • Johnson & Johnson
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Viatris Inc.
  • ALZA Corporation
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Sanofi S.A.
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • AstraZeneca plc
  • Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY MATERIAL- MARKET ANALYSIS, 2019-2032

  • Polymer-based
  • Non-polymer Based

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY DOSAGE FORM- MARKET ANALYSIS, 2019-2032

  • Long Acting Injectables
  • Long Acting Implantable
  • Long-acting Oral
  • Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Pharmaceutical & Biotech Companies
  • Research & Development
  • Others

GLOBAL LONG-ACTING DRUG DELIVERY TECHNOLOGIES AND SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Long-Acting Drug Delivery Technologies and Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Long-Acting Drug Delivery Technologies and Services Market Snippet by Material
    • 2.1.2. Long-Acting Drug Delivery Technologies and Services Market Snippet by Dosage Form
    • 2.1.3. Long-Acting Drug Delivery Technologies and Services Market Snippet by End User
    • 2.1.4. Long-Acting Drug Delivery Technologies and Services Market Snippet by Country
    • 2.1.5. Long-Acting Drug Delivery Technologies and Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Long-Acting Drug Delivery Technologies and Services Key Market Trends

  • 3.1. Long-Acting Drug Delivery Technologies and Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Long-Acting Drug Delivery Technologies and Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Long-Acting Drug Delivery Technologies and Services Market Opportunities
  • 3.4. Long-Acting Drug Delivery Technologies and Services Market Future Trends

4. Long-Acting Drug Delivery Technologies and Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Long-Acting Drug Delivery Technologies and Services Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Long-Acting Drug Delivery Technologies and Services Market Landscape

  • 6.1. Long-Acting Drug Delivery Technologies and Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Long-Acting Drug Delivery Technologies and Services Market - By Material

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material, 2024 & 2032 (%)
    • 7.1.2. Polymer-based
    • 7.1.3. Non-polymer Based

8. Long-Acting Drug Delivery Technologies and Services Market - By Dosage Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Dosage Form, 2024 & 2032 (%)
    • 8.1.2. Long Acting Injectables
    • 8.1.3. Long Acting Implantable
    • 8.1.4. Long-acting Oral
    • 8.1.5. Others

9. Long-Acting Drug Delivery Technologies and Services Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Pharmaceutical & Biotech Companies
    • 9.1.3. Research & Development
    • 9.1.4. Others

10. Long-Acting Drug Delivery Technologies and Services Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Long-Acting Drug Delivery Technologies and Services Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Material, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Dosage Form, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Long-Acting Drug Delivery Technologies and Services Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Roche Holding AG
    • 11.2.3. Novartis International AG
    • 11.2.4. Johnson & Johnson
    • 11.2.5. Boehringer Ingelheim
    • 11.2.6. Bristol-Myers Squibb
    • 11.2.7. Viatris Inc.
    • 11.2.8. ALZA Corporation
    • 11.2.9. Eli Lilly and Company
    • 11.2.10. Merck & Co., Inc.
    • 11.2.11. Sanofi S.A.
    • 11.2.12. AbbVie Inc.
    • 11.2.13. Gilead Sciences, Inc.
    • 11.2.14. GlaxoSmithKline plc
    • 11.2.15. AstraZeneca plc
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us